Global Fibrinogen Market, 2020-2026

March 2020 | 96 pages | ID: GB1CC780EC7FEN
Gen Consulting Company

Abstracts

Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. The native molecule is a dimer and consists of three pairs of polypeptide chains (A?, B? and ?). Fibrinogen finds application in the treatment of fibrinogen deficiencies and control of bleeding during surgeries. According to Gen Consulting Company, global fibrinogen market is expected to reach USD 1,935.8 million by the end of 2026, expanding at a CAGR of 6.11% over the forecast period i.e. 2020-2026. Growing potential for fibrinogen in haemostatic therapy sector is the chief contributor for the growth of the market.

The fibrinogen market is segmented on the basis of application, and region. By application, the fibrinogen market is classified into Haemostatic Therapy, Research Use. On the basis of region, the fibrinogen industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).

By Application:

• Haemostatic Therapy
• Research Use

By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.

• North America (U.S., Canada, Mexico, etc.)
• Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
• Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
• South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)

The market research report covers the analysis of key stake holders of the fibrinogen market. Some of the leading players profiled in the report include:

• Baxter International Inc.
• CSL Behring LLC
• Green Cross Corporation
• Harbin Pacific Biopharmaceutical Co., Ltd.
• Hualan Biological Engineering Inc.
• Jiangxi Boya Bio-Pharmaceutical Co., Ltd.
• Johnson & Johnson (Ethicon, Inc.)
• LFB S.A.
• ProFibrix BV (The Medicines Company)
• Shanghai RAAS Blood Products Co., Ltd.
• Shanghai Xinxing Medicine Co., Ltd.

*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective

• To analyze and forecast the market size of global fibrinogen market.
• To classify and forecast global fibrinogen market based on application, and region.
• To identify drivers and challenges for global fibrinogen market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global fibrinogen market.
• To conduct pricing analysis for global fibrinogen market.
• To identify and analyze the profile of leading players operating in global fibrinogen market.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:

• Manufacturers of fibrinogen
• Raw material suppliers
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to fibrinogen

Contents

PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Consumers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitute Products and Services
  4.5.5 Degree of Competition

PART 7. GLOBAL MARKET FOR FIBRINOGEN BY APPLICATION

7.1 Market Overview
7.2 Haemostatic Therapy
  7.2.1 Market Size and Forecast
7.3 Research Use
  7.3.1 Market Size and Forecast

PART 8. GLOBAL MARKET FOR FIBRINOGEN BY GEOGRAPHY

8.1 Overview
  8.1.1 Market Size and Forecast
8.2 North America
  8.2.1 Market Size and Forecast
  8.2.2 North America: Fibrinogen Market by Country
    8.2.2.1 United States
    8.2.2.2 Canada
    8.2.2.3 Mexico
8.3 Europe
  8.3.1 Market Size and Forecast
  8.3.2 Europe: Fibrinogen Market by Country
    8.3.2.1 Germany
    8.3.2.2 France
    8.3.2.3 United Kingdom
    8.3.2.4 Italy
    8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
  8.4.1 Market Size and Forecast
  8.4.2 Asia-Pacific: Fibrinogen Market by Country
    8.4.2.1 China
    8.4.2.2 India
    8.4.2.3 Japan
    8.4.2.4 South Korea
    8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
  8.5.1 Market Size and Forecast
  8.5.2 MEA: Fibrinogen Market by Country
    8.5.2.1 Saudi Arabia
    8.5.2.2 South Africa
    8.5.2.3 Turkey
8.6 South America
  8.6.1 Market Size and Forecast
  8.6.2 South America: Fibrinogen Market by Country
    8.6.2.1 Brazil
    8.6.2.2 Argentina
    8.6.2.3 Rest of South America

PART 9. COMPETITIVE LANDSCAPE

9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

PART 10. KEY COMPETITOR PROFILES

10.1 Baxter International Inc.
10.2 CSL Behring LLC
10.3 Green Cross Corporation
10.4 Harbin Pacific Biopharmaceutical Co., Ltd.
10.5 Hualan Biological Engineering Inc.
10.6 Jiangxi Boya Bio-Pharmaceutical Co., Ltd.
10.7 Johnson & Johnson (Ethicon, Inc.)
10.8 LFB S.A.
10.9 ProFibrix BV (The Medicines Company)
10.10 Shanghai RAAS Blood Products Co., Ltd.
10.11 Shanghai Xinxing Medicine Co., Ltd.
*LIST IS NOT EXHAUSTIVE

PART 11. PATENT ANALYSIS

11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis

DISCLAIMER

About

ABOUT GEN CONSULTING COMPANY